Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Snigdha VallabhaneniTom Chiller

Abstract

November 11, 2016/65(44);1234-1237. What is already known about this topic? Candida auris is an emerging pathogenic fungus that has been reported from at least a dozen countries on four continents during 2009-2015. The organism is difficult to identify using traditional biochemical methods, some isolates have been found to be resistant to all three major classes of antifungal medications, and C. auris has caused health care-associated outbreaks. What is added by this report? This is the first description of C. auris cases in the United States. C. auris appears to have emerged in the United States only in the last few years, and U.S. isolates are related to isolates from South America and South Asia. Evidence from U.S. case investigations suggests likely transmission of the organism occurred in health care settings. What are the implications for public health practice? It is important that U.S. laboratories accurately identify C. auris and for health care facilities to implement recommended infection control practices to prevent the spread of C. auris. Local and state health departments and CDC should be notified of possible cases of C. auris and of isolates of C. haemulonii and Candida spp. that cannot be identified after routi...Continue Reading

References

Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher

❮ Previous
Next ❯

Citations

May 19, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marwan M AzarVirginia M Pierce
Jul 12, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Christina T PiedrahitaCurtis J Donskey
Feb 7, 2018·Current Infectious Disease Reports·Ilan S Schwartz, Thomas F Patterson
Mar 31, 2018·Antimicrobial Resistance and Infection Control·Marie-Elisabeth BougnouxJean-Ralph Zahar
Nov 22, 2017·Antimicrobial Agents and Chemotherapy·Ruvini U PathiranaMira Edgerton
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annette L JencsonCurtis J Donskey
Apr 11, 2018·Antimicrobial Agents and Chemotherapy·Milena KordalewskaDavid S Perlin
Nov 24, 2017·Future Microbiology·Glauber R de S AraújoSusana Frases
Nov 8, 2017·Expert Review of Anti-infective Therapy·Matthew William McCarthy, Thomas J Walsh
May 23, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patricia EscandónTom M Chiller
Nov 24, 2017·Journal of Clinical Microbiology·Emily S Spivak, Kimberly E Hanson
Aug 30, 2017·Antimicrobial Agents and Chemotherapy·Hamed FakhimHamid Badali
Dec 6, 2018·Acta Clinica Belgica·Klaas DewaeleKatrien Lagrou
Oct 25, 2017·Nature Microbiology·Rebecca S ShapiroJames J Collins
Nov 22, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jennifer L CadnumCurtis J Donskey
Aug 11, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jennifer L CadnumCurtis J Donskey
Apr 29, 2018·Current Infectious Disease Reports·Geehan SuleymanAna Cecilia Bardossy
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Sep 7, 2017·Expert Opinion on Drug Discovery·Tsun Sheng N KuSamuel A Lee
Oct 28, 2019·Journal of Fungi·Amal Al MaaniAbdullah M S Al-Hatmi
Sep 27, 2019·Medical Microbiology and Immunology·Moses MadendeCarolina H Pohl
Sep 21, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vijeta BajpaiPurva Mathur
Jan 15, 2020·Antimicrobial Agents and Chemotherapy·Brittany O'BrienVishnu Chaturvedi
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh
Dec 22, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Matthew CooperAndrew B Adams
Jun 2, 2020·Journal of Medical Microbiology·Michael MalczynskiChao Qi
Apr 17, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Amira ElBaradei
Aug 9, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ahmed BabikerMary K Hayden
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyAnup Ghosh
Aug 8, 2018·Medical Mycology·Kaitlin ForsbergSnigdha Vallabhaneni
Nov 7, 2018·Journal of Intensive Care·Andrea CortegianiAnuradha Chowdhary
Dec 24, 2018·Materials·Katarzyna Ledwoch, Jean-Yves Maillard
Sep 5, 2019·Frontiers in Microbiology·Milena Kordalewska, David S Perlin
Mar 17, 2018·Archives of Disease in Childhood·Adilia Warris
May 18, 2018·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·I S Schwartz, G W Hammond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.